These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 1578221

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins.
    Varma M, Rudolph DL, Knuchel M, Switzer WM, Hadlock KG, Velligan M, Chan L, Foung SK, Lal RB.
    J Clin Microbiol; 1995 Dec; 33(12):3239-44. PubMed ID: 8586709
    [Abstract] [Full Text] [Related]

  • 4. Type- and group-specific continuous antigenic determinants of HTLV. Use of synthetic peptides for serotyping of HTLV-I and -II infection.
    Blomberg J, Robert-Guroff M, Blattner WA, Pipkorn R.
    J Acquir Immune Defic Syndr (1988); 1992 Dec; 5(3):294-302. PubMed ID: 1371319
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Serological and molecular evidence of infection by human T-cell lymphotropic virus type II in Italian drug addicts by use of synthetic peptides and polymerase chain reaction.
    De Rossi A, Mammano F, Del Mistro A, Chieco-Bianchi L.
    Eur J Cancer; 1991 Dec; 27(7):835-8. PubMed ID: 1834112
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-II.
    Bonis J, Baillou A, Barin F, Verdier M, Janvier B, Denis F.
    J Clin Microbiol; 1993 Jun; 31(6):1481-5. PubMed ID: 8314990
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Primary isolation of human T-cell leukemia-lymphoma virus types I and II: use for confirming infection in seroindeterminate blood donors.
    Hjelle B, Mills R, Goldsmith C, Swenson SG, Cyrus S.
    J Clin Microbiol; 1992 Aug; 30(8):2195-9. PubMed ID: 1500534
    [Abstract] [Full Text] [Related]

  • 14. Discrimination of human T-lymphotropic virus type-I and type-II infections by synthetic peptides representing structural epitopes from the envelope glycoproteins.
    Rudolph DL, Lal RB.
    Clin Chem; 1993 Feb; 39(2):288-92. PubMed ID: 7679339
    [Abstract] [Full Text] [Related]

  • 15. Sensitive and specific polymerase chain reaction assays for diagnosis of human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections in HTLV-I/II-seropositive individuals.
    Heneine W, Khabbaz RF, Lal RB, Kaplan JE.
    J Clin Microbiol; 1992 Jun; 30(6):1605-7. PubMed ID: 1624585
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Typing human T-cell lymphotropic virus (HTLV-I and HTLV-II) by nested polymerase chain reaction: application to clinical specimens.
    Vallejo A, García-Sáiz A.
    J Virol Methods; 1995 Jan; 51(1):9-17. PubMed ID: 7730441
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.